BioTech & MedTech Startups
Attract investment & partnerships
We help universities, research institutes, and hospitals communicate scientific progress, share expertise, and demonstrate impact to funders, peers, and the public.
We help academic and clinical institutions increase visibility for their research, programs, and initiatives. Through clear messaging, visual storytelling, and digital presence, we make complex scientific work accessible to broader audiences, including funders, collaborators, policymakers, and patients.
We translate research findings, clinical insights, and educational content into clear, engaging formats such as scientific visuals, explainer videos, presentations, and digital content. These assets support knowledge exchange between researchers, clinicians, students, and external stakeholders - helping institutions position themselves as leaders in their fields.
Many academic and clinical projects funded through programs such as Horizon 2020 require regular reporting and public demonstration of progress. We support you with high-quality visual and digital materials that clearly show research milestones, methodologies, and outcomes, helping institutions meet dissemination requirements and communicate real-world impact.
Strategy
ROI
Technology
Onboarding a new agency can be challenging, but it's worthwhile for NANOBOT! Additionally, we're ready to co-invest up to 50% in our initial project that requires fewer than 100 hours.
Raise your profile with investors and partners by connecting at events like JP Morgan.
3x increase your productivity with software automation.
* We actively support academic and non-commercial research initiatives and offer special pricing for universities and hospitals, including a 10% discount, to ensure high-quality scientific communication is accessible to research-driven organizations.
Children's Hospital of Philadelphia (CHOP) is the first hospital in the US devoted exclusively to the care of children. The "New Frontiers" project by the CHOP aims to find and diagnose rare mutations in children.
KU Leuven is an international community where innovative research forms the basis of all academic programs. JOINTPROMISE project paves the way for high-volume, affordable production of entire biological joints, addressing a major socioeconomic challenge of the European ageing society.

Book a one-hour free consultation with our Marketing Expert